330 related articles for article (PubMed ID: 24816989)
1. The role of 5-hydroxymethylcytosine in human cancer.
Pfeifer GP; Xiong W; Hahn MA; Jin SG
Cell Tissue Res; 2014 Jun; 356(3):631-41. PubMed ID: 24816989
[TBL] [Abstract][Full Text] [Related]
2. Loss of 5-hydroxymethylcytosine in cancer: cause or consequence?
Ficz G; Gribben JG
Genomics; 2014 Nov; 104(5):352-7. PubMed ID: 25179374
[TBL] [Abstract][Full Text] [Related]
3. Ten eleven translocation enzymes and 5-hydroxymethylation in mammalian development and cancer.
Kinney SR; Pradhan S
Adv Exp Med Biol; 2013; 754():57-79. PubMed ID: 22956496
[TBL] [Abstract][Full Text] [Related]
4. Tet family proteins and 5-hydroxymethylcytosine in development and disease.
Tan L; Shi YG
Development; 2012 Jun; 139(11):1895-902. PubMed ID: 22569552
[TBL] [Abstract][Full Text] [Related]
5. Lead exposure induces changes in 5-hydroxymethylcytosine clusters in CpG islands in human embryonic stem cells and umbilical cord blood.
Sen A; Cingolani P; Senut MC; Land S; Mercado-Garcia A; Tellez-Rojo MM; Baccarelli AA; Wright RO; Ruden DM
Epigenetics; 2015; 10(7):607-21. PubMed ID: 26046694
[TBL] [Abstract][Full Text] [Related]
6. The role of 5-hydroxymethylcytosine in development, aging and age-related diseases.
López V; Fernández AF; Fraga MF
Ageing Res Rev; 2017 Aug; 37():28-38. PubMed ID: 28499883
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer.
Storebjerg TM; Strand SH; Høyer S; Lynnerup AS; Borre M; Ørntoft TF; Sørensen KD
Clin Epigenetics; 2018 Aug; 10(1):105. PubMed ID: 30086793
[TBL] [Abstract][Full Text] [Related]
8. Acetylation Enhances TET2 Function in Protecting against Abnormal DNA Methylation during Oxidative Stress.
Zhang YW; Wang Z; Xie W; Cai Y; Xia L; Easwaran H; Luo J; Yen RC; Li Y; Baylin SB
Mol Cell; 2017 Jan; 65(2):323-335. PubMed ID: 28107650
[TBL] [Abstract][Full Text] [Related]
9. 5-Hydroxymethylcytosine: a stable or transient DNA modification?
Hahn MA; Szabó PE; Pfeifer GP
Genomics; 2014 Nov; 104(5):314-23. PubMed ID: 25181633
[TBL] [Abstract][Full Text] [Related]
10. Loss of 5-hydroxymethylcytosine is linked to gene body hypermethylation in kidney cancer.
Chen K; Zhang J; Guo Z; Ma Q; Xu Z; Zhou Y; Xu Z; Li Z; Liu Y; Ye X; Li X; Yuan B; Ke Y; He C; Zhou L; Liu J; Ci W
Cell Res; 2016 Jan; 26(1):103-18. PubMed ID: 26680004
[TBL] [Abstract][Full Text] [Related]
11. 5-hydroxymethylcytosine marks regions with reduced mutation frequency in human DNA.
Tomkova M; McClellan M; Kriaucionis S; Schuster-Boeckler B
Elife; 2016 May; 5():. PubMed ID: 27183007
[TBL] [Abstract][Full Text] [Related]
12. Distinct and overlapping control of 5-methylcytosine and 5-hydroxymethylcytosine by the TET proteins in human cancer cells.
Putiri EL; Tiedemann RL; Thompson JJ; Liu C; Ho T; Choi JH; Robertson KD
Genome Biol; 2014 Jun; 15(6):R81. PubMed ID: 24958354
[TBL] [Abstract][Full Text] [Related]
13. Genomic distribution and possible functions of DNA hydroxymethylation in the brain.
Wen L; Tang F
Genomics; 2014 Nov; 104(5):341-6. PubMed ID: 25205307
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation: TET proteins-guardians of CpG islands?
Williams K; Christensen J; Helin K
EMBO Rep; 2011 Dec; 13(1):28-35. PubMed ID: 22157888
[TBL] [Abstract][Full Text] [Related]
15. A Strategy for Accurate Quantification of 5-Methylcytosine and 5-Hydroxymethylcytosine at CpG Sites Within Gene Promoter.
Qui Y; Yang Q; Sui F; Lu R; Dang S; Ji M; He N; Shi B; Hou P
J Biomed Nanotechnol; 2015 Jun; 11(6):1016-26. PubMed ID: 26353591
[TBL] [Abstract][Full Text] [Related]
16. 5-Hydroxymethylcytosine: An epigenetic mark frequently deregulated in cancer.
Kroeze LI; van der Reijden BA; Jansen JH
Biochim Biophys Acta; 2015 Apr; 1855(2):144-54. PubMed ID: 25579174
[TBL] [Abstract][Full Text] [Related]
17. Examination of the specificity of DNA methylation profiling techniques towards 5-methylcytosine and 5-hydroxymethylcytosine.
Jin SG; Kadam S; Pfeifer GP
Nucleic Acids Res; 2010 Jun; 38(11):e125. PubMed ID: 20371518
[TBL] [Abstract][Full Text] [Related]
18. Global changes in DNA methylation and hydroxymethylation in Alzheimer's disease human brain.
Coppieters N; Dieriks BV; Lill C; Faull RL; Curtis MA; Dragunow M
Neurobiol Aging; 2014 Jun; 35(6):1334-44. PubMed ID: 24387984
[TBL] [Abstract][Full Text] [Related]
19. 5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations.
Jin SG; Jiang Y; Qiu R; Rauch TA; Wang Y; Schackert G; Krex D; Lu Q; Pfeifer GP
Cancer Res; 2011 Dec; 71(24):7360-5. PubMed ID: 22052461
[TBL] [Abstract][Full Text] [Related]
20. DNA repair enzymes ALKBH2, ALKBH3, and AlkB oxidize 5-methylcytosine to 5-hydroxymethylcytosine, 5-formylcytosine and 5-carboxylcytosine in vitro.
Bian K; Lenz SAP; Tang Q; Chen F; Qi R; Jost M; Drennan CL; Essigmann JM; Wetmore SD; Li D
Nucleic Acids Res; 2019 Jun; 47(11):5522-5529. PubMed ID: 31114894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
